Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sholpan Ryskeldinova"'
Autor:
Dina Bugybayeva, Zhailaubay Kydyrbayev, Nadezhda Zinina, Nurika Assanzhanova, Bolat Yespembetov, Yerken Kozhamkulov, Kunsulu Zakarya, Sholpan Ryskeldinova, Kaissar Tabynov
Publikováno v:
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)
Abstract Background A new candidate vector vaccine against human brucellosis based on recombinant influenza viral vectors (rIVV) subtypes H5N1 expressing Brucella outer membrane protein (Omp) 16, L7/L12, Omp19 or Cu–Zn SOD proteins has been develop
Externí odkaz:
https://doaj.org/article/8aba2cd3013e419caa0f6e55a4ebcb48
Autor:
Sholpan Ryskeldinova, Nadezhda Zinina, Zhailaubay Kydyrbayev, Bolat Yespembetov, Yerken Kozhamkulov, Dulat Inkarbekov, Nurika Assanzhanova, Aigerim Mailybayeva, Dina Bugybayeva, Makhpal Sarmykova, Berik Khairullin, Kairat Tabynov, Aitbay Bulashev, Batyrbek Aitzhanov, Khairulla Abeuov, Abylay Sansyzbay, Tlektes Yespolov, Gourapura J. Renukaradhya, Steven Olsen, Angel Oñate, Kaissar Tabynov
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
A novel influenza viral vector based Brucella abortus vaccine (Flu-BA) was introduced for use in cattle in Kazakhstan in 2019. In this study, the safety and efficacy of the vaccine was evaluated in male and female cattle at different ages, and during
Externí odkaz:
https://doaj.org/article/784af5d432594b998f20c7744699fd56
Autor:
Aigerim Mailybayeva, Sholpan Ryskeldinova, Nadezhda Zinina, En-Min Zhou, Gourapura J. Renukaradhya, Kaissar Tabynov
Publikováno v:
Frontiers in Veterinary Science, Vol 7 (2020)
In this study, we first evaluated the duration of a protective immune response against Brucella melitensis infection in non-pregnant sheep and goats immunized with an improved (by vaccine formulation and route of administration) commercial Brucella a
Externí odkaz:
https://doaj.org/article/b6827acbbf6646ba874271272e88a380
Publikováno v:
Ciência Rural, Vol 46, Iss 1, Pp 114-118 (2016)
ABSTRACT: The present study provides the first information about the safety of a new influenza viral vector vaccine expressing the Brucella ribosomal protein L7/L12 or Omp16 containing the adjuvant Montanide Gel01 in pregnant heifers. Immunization of
Externí odkaz:
https://doaj.org/article/fc9132afd2c349f7a94aadbb1b24c2db
Autor:
Aigerim Mailybayeva, Bolat Yespembetov, Sholpan Ryskeldinova, Nadezhda Zinina, Abylai Sansyzbay, Gourapura J Renukaradhya, Nikolai Petrovsky, Kaissar Tabynov
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186484 (2017)
We previously developed a potent candidate vaccine against bovine brucellosis caused by Brucella abortus using the influenza viral vector expressing Brucella Omp16 and L7/L12 proteins (Flu-BA). Our success in the Flu-BA vaccine trial in cattle and re
Externí odkaz:
https://doaj.org/article/fa3d9ae76ed54046bcf48aa85db88ca5
Autor:
Sholpan Ryskeldinova, Zhailaubay Kydyrbayev, Dina Bugybayeva, Kaissar Tabynov, Yerken Kozhamkulov, Bolat Yespembetov, Nurika Assanzhanova, Nadezhda Zinina, Kunsulu Zakarya
Publikováno v:
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-10 (2021)
Infectious Diseases of Poverty
Infectious Diseases of Poverty
Background A new candidate vector vaccine against human brucellosis based on recombinant influenza viral vectors (rIVV) subtypes H5N1 expressing Brucella outer membrane protein (Omp) 16, L7/L12, Omp19 or Cu–Zn SOD proteins has been developed. This
Autor:
Dina Bugybayeva, Kunsulu Zakarya, Zhailaubay Kydyrbayev, Bolat Yespembetov, Yerken Kozhamkulov, Sholpan Ryskeldinova, Nadezhda Zinina, Nurika Assanzhanova, Kaissar Tabynov
Background: A new candidate vector vaccine against human brucellosis based on recombinant influenza viral vectors (rIVV) subtypes H5N1 expressing Brucella Omp16, L7/L12, Omp19 or Cu-Zn SOD proteins has been developed. This paper presents the results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05066be49eb68e57f3f64c78c263758b
https://doi.org/10.21203/rs.3.rs-56762/v1
https://doi.org/10.21203/rs.3.rs-56762/v1
Autor:
Dina Bugybayeva, Nurika Assanzhanova, Makhpal K. Sarmykova, Kaissar Tabynov, Nadezhda Zinina, Zhailaubay Kydyrbayev, Sholpan Ryskeldinova
Publikováno v:
BioMed Research International, Vol 2020 (2020)
BioMed Research International
BioMed Research International
In this paper, we first used recombinant influenza viral vector (rIVV) subtype H5N1 expressing from the open reading frame of NS1 80 and NS1 124 amino acids of Brucella outer membrane proteins (Omp) 16 and 19, ribosomal L7/L12, and Cu-Zn superoxide d
Autor:
Zhailaubay Kydyrbayev, Nurika Assanzhanova, Aigerim Mailybayeva, Dina Bugybayeva, Erken Kozhamkulov, Sholpan Ryskeldinova
Publikováno v:
Advances in Animal and Veterinary Sciences. 8
Autor:
Aigerim, Mailybayeva, Sholpan, Ryskeldinova, Nadezhda, Zinina, En-Min, Zhou, Gourapura J, Renukaradhya, Kaissar, Tabynov
Publikováno v:
Frontiers in Veterinary Science
In this study, we first evaluated the duration of a protective immune response against Brucella melitensis infection in non-pregnant sheep and goats immunized with an improved (by vaccine formulation and route of administration) commercial Brucella a